Sanofi India · NSE: SANOFI · BSE: 500674
Q1 FY23 results · Apr–Jun 2022
Sanofi India reported revenue from operations of ₹699.30 crore (down 11.4% from Q1 FY22) and net profit of ₹120.40 crore (down 32.5% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a standalone basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 699.30 | 789.10 | −11.4% | 707.00 | −1.1% |
| Other income | 15.70 | 17.10 | −8.2% | 24.40 | −35.7% |
| Total income | 715.00 | 806.20 | −11.3% | 731.40 | −2.2% |
| Profit before tax | 165.80 | 242.60 | −31.7% | 325.70 | −49.1% |
| Net profit for the period | 120.40 | 178.30 | −32.5% | 238.40 | −49.5% |
| EPS, basic (₹) | 52.28 | 77.42 | −32.5% | 103.51 | −49.5% |
| Net margin (%) | 17.2 | 22.6 | 33.7 |
Standalone
- Filed with BSE
- 28 Jul 2022, 09:59 IST
- Board meeting
- 26 Jul 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE